DEINOVE Logo

DEINOVE

ALDEI | PA

Overview

Corporate Details

ISIN(s):
FR0010879056 (+1 more)
LEI:
969500BEJSRFER0F2K08
Country:
France
Address:
1682 RUE DE LA VALSIERE, 34790 GRABELS
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

DEINOVE is a French biotechnology company pioneering the exploration of a new domain of life, unexplored at 99.9%: the “microbial dark matter”. By revealing the metabolic potential of rare bacteria or still classified as uncultivable, it tackles a global health and economic challenge: antimicrobial resistance. The new therapies discovered and developed by DEINOVE target superbugs (microbes that have become resistant to one or more antimicrobials) that cause life-threatening infections which are now spreading at high speed.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2023-01-24 17:45
Legal Proceedings Report
Conversion de la procédure de redressement judiciaire en liquidation judiciaire
French 80.4 KB
2023-01-24 17:45
Legal Proceedings Report
Conversion of the receivership proceedings into judicial liquidation proceedings
English 67.6 KB
2023-01-16 19:09
Legal Proceedings Report
DEINOVE - Point sur la procédure de redressement judiciaire
French 79.4 KB
2023-01-16 19:09
Legal Proceedings Report
DEINOVE - Update on the receivership proceedings
English 66.5 KB
2022-12-16 18:10
Legal Proceedings Report
DEINOVE - Point sur la Procédure de Redressement Judiciaire
French 80.2 KB
2022-12-16 18:10
Legal Proceedings Report
DEINOVE - Update on the Receivership Proceedings
English 67.5 KB
2022-11-07 17:45
Legal Proceedings Report
Deinove annonce L’ouverture d’une procédure de redressement judiciaire
French 72.0 KB
2022-11-07 17:45
Legal Proceedings Report
Deinove Announces the Opening of Receivership Proceedings
English 89.5 KB
2022-10-28 17:51
Legal Proceedings Report
DEINOVE REQUESTS RECEIVERSHIP PROCEEDINGS
English 67.6 KB
2022-10-28 17:51
Legal Proceedings Report
DEINOVE SOLLICITE UNE PROCÉDURE DE REDRESSEMENT JUDICIAIRE
French 68.6 KB
2022-10-20 17:45
Post-Annual General Meeting Information
DEINOVE - Adoption of the resolutions at the Shareholders’ Extraordinary Genera…
English 69.8 KB
2022-10-20 17:45
Post-Annual General Meeting Information
DEINOVE - Adoption de l'ensemble des résolutions de son Assemblée Générale Extr…
French 71.2 KB
2022-10-10 17:45
Post-Annual General Meeting Information
DEINOVE - Extraordinary General Meeting of October 17, 2022: Appointment of an …
English 86.3 KB
2022-10-10 17:45
Pre-Annual General Meeting Information
DEINOVE- Assemblée générale extraordinaire du 17 octobre 2022 : Désignation d'u…
French 88.2 KB
2022-10-06 19:02
Earnings Release
DEINOVE présente ses résultats financiers et l’avancée de ses programmes pour l…
French 239.0 KB

Automate Your Workflow. Get a real-time feed of all DEINOVE filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for DEINOVE via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Read Gene Spolka Akcyjna Logo
Develops DNA tests to identify genetic cancer risk for early detection and prevention.
Poland RDG
RELIEF Therapeutics Holding AG Logo
Developing and commercializing novel therapies for rare and ultra-rare diseases.
Switzerland RLF
RYVU Therapeutics S.A. Logo
Clinical-stage drug discovery company developing novel small molecule therapies for oncology.
Poland RVU
SAREUM HOLDINGS PLC Logo
Clinical-stage developer of kinase inhibitors for autoimmune disease & cancer.
United Kingdom SAR
SCANCELL HOLDINGS PLC Logo
Developing therapeutic vaccines and antibodies for cancer and infectious diseases.
United Kingdom SCLP
SCIENCE GROUP PLC Logo
International science & tech consultancy providing advisory, R&D, and product development.
United Kingdom SAG
Selvita S.A. Logo
Preclinical CRO offering integrated drug discovery and development services for life sciences.
Poland SLV
Simris Group AB Logo
Develops novel cyanobacteria-based payloads for Antibody-Drug Conjugates to treat cancer.
Sweden SIMRIS
SKINBIOTHERAPEUTICS PLC Logo
A life science company developing microbiome-based skin health products and supplements.
United Kingdom SBTX
Terranet B Logo
Develops ultra-fast ADAS anti-collision technology for automakers to protect vulnerable road users.
Sweden TERRNT

Talk to a Data Expert

Have a question? We'll get back to you promptly.